Cargando…

Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells

Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication. Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis. Particularly, idiopathic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Weijuan, Mu, Wenbo, Zeifman, Amy, Lofti, Michelle, Remillard, Carmelle V., Makino, Ayako, Perkins, David L., Garcia, Joe G., Yuan, Jason X. J., Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224433/ https://www.ncbi.nlm.nih.gov/pubmed/22140631 http://dx.doi.org/10.4103/2045-8932.87310

Ejemplares similares

Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels
por: Firth, Amy L., et al.
Publicado: (2011)

Activity of Ca(2+) -activated Cl(-) channels contributes to regulating receptor- and store-operated Ca(2+) entry in human pulmonary artery smooth muscle cells
por: Yamamura, Aya, et al.
Publicado: (2011)

Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023)

Fenfluramine in the treatment of hypertensive patients with refractory obesity.
por: Scott, M. E., et al.
Publicado: (1975)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Risk of valvular heart disease associated with use of fenfluramine
por: Hopkins, Paul N, et al.
Publicado: (2003)

A review of fenfluramine for the treatment of Dravet syndrome patients
por: Simon, Kayla, et al.
Publicado: (2021)

In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022)

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

STIM2 contributes to enhanced store-operated Ca(2+) entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension
por: Song, Michael Y., et al.
Publicado: (2011)

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy
por: Samanta, Debopam
Publicado: (2022)

Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
por: Dahl, Charles F, et al.
Publicado: (2008)

Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis
por: Tabaee Damavandi, Payam, et al.
Publicado: (2023)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
por: Guerrini, Renzo, et al.
Publicado: (2022)

Age-Associated Dysregulation of Integrin Function in Vascular Smooth Muscle
por: Ojha, Krishna Raj, et al.
Publicado: (2022)

In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022)

The anorexic effect of DL-fenfluramine is dependent on animals' habituation to different food types
por: Yi, Sun Shin, et al.
Publicado: (2022)

Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
por: Dini, Gianluca, et al.
Publicado: (2023)

Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
por: Sourbron, Jo, et al.
Publicado: (2017)

Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome
por: Millett, David, et al.
Publicado: (2021)

Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome
por: Li, Jing, et al.
Publicado: (2021)

Endothelial–Vascular Smooth Muscle Cells Interactions in Atherosclerosis
por: Li, Manna, et al.
Publicado: (2018)

Upregulation of Calcium Homeostasis Modulators in Contractile-To-Proliferative Phenotypical Transition of Pulmonary Arterial Smooth Muscle Cells
por: Rodriguez, Marisela, et al.
Publicado: (2021)

Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome
por: Dale, Matthew, et al.
Publicado: (2017)

Vascular smooth muscle cells direct extracellular dysregulation in aortic stiffening of hypertensive rats
por: Hays, Tristan T., et al.
Publicado: (2018)

3123 TGFbeta, Early Cytokine Dysregulation, and Airway Smooth Muscle Dysfunction in Cystic Fibrosis
por: Kramer, Elizabeth L, et al.
Publicado: (2019)

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series
por: Aledo‐Serrano, Ángel, et al.
Publicado: (2022)

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Wijnen, Ben, et al.
Publicado: (2022)

Outgrowing endothelial and smooth muscle cells for tissue engineering approaches
por: Kolster, Moritz, et al.
Publicado: (2017)

Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells
por: Raman, Priya, et al.
Publicado: (2021)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

Correction: Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome
por: Dale, Matthew, et al.
Publicado: (2018)

Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells
Publicado: (1987)

Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells
por: Chen, Qi, et al.
Publicado: (2016)

Collateral Vessels Have Unique Endothelial and Smooth Muscle Cell Phenotypes
por: Zhang, Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36s6ilp65em7ivr02o3itloh42